14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Fri, 26 Apr 2024

Trading levels for CMRX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.96 8.03 %
R2 0.94 5.52 %
R1 0.93 3.98 %
Current price: 0.89
Support S1 0.88 -1.03 %
S2 0.87 -2.58 %
S3 0.85 -5.08 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.05 17.85 %
R2 1.04 16.72 %
R1 0.96 7.74 %
Current price 0.89
Support S1 0.88 -0.741%
S2 0 .
S3 0 .

CMRX Predictions History

1 year ago
rwmusa.358585 predicted that CMRX for 2023-01-17 is going

Rank:

1 year ago
glmaof predicted that CMRX for 2022-12-02 is going

Rank:

3 years ago
JS predicted that CMRX for 2020-05-11 is going $2.80 (-9.97%)

3 years ago
MacSteele13 predicted that CMRX for 2020-05-11 is going

Rank:

4 years ago
PumpTheseNumbers predicted that CMRX for 2019-05-15 is going $3.56 (-3.26%)

4 years ago
joe1234 predicted that CMRX for 2019-05-15 is going $3.49 (-5.16%)

4 years ago
NameNotImportant predicted that CMRX for 2019-05-06 is going $2.79 (3.33%)

5 years ago
NameNotImportant predicted that CMRX for 2019-04-24 is going $2.61 (2.76%)

5 years ago
NameNotImportant predicted that CMRX for 2019-04-23 is going $2.76 (1.47%)

5 years ago
PumpTheseNumbers predicted that CMRX for 2019-04-10 is going $2.60 (-7.14%)

Click to get the best stock tips daily for free!

About Chimerix

Chimerix Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs include ONC201 a program for treating tumors which harbor the H3 K27M mutation in recurrent diffuse midl... CMRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT